7 Animals That Hold World Records
Anaika Sohal
May 17, 2025
They are the fastest land animals, with a record of running up to 112 km/ hr. And they hold the title of the fastest land speed, reaching 0 to 96 km/hr in just 3 seconds.
They have the record of reaching 30 meters in length and weighing up to 180 tons, and they are bigger than any dinosaur, heaviest also.
These birds can dive at a speed of over 380 km per her and are the first animal on the planet when diving to catch prey.
The male Giraffe can grow up to 5.9 meters tall and their long necks help them to reach the leaves high in the tree and also spot predators.
They have the record of weighing over 12,000 kg and standing up to 4 meters, and they are not only the tallest but also intelligent and emotionally complex.
These aquatic species have the record of eyes that can reach up to 30-40 cm in diameter and perfect for spotting predators in the pitch-black waters.
These tiny jellyfish can revert to its juvenile state and theoretically escape death, they can basically reverse its age. ( Image Credits: iStock) Read Next Story
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
3 hours ago
- Time of India
Good oil has its limits too: Why olive oil may be expanding your waistline, one fat cell at a time
Olive oil has long been hailed as a golden elixir of health, praised by Mediterranean diets and wellness gurus alike. But a new study has stirred the pot — and your salad dressing — by revealing a surprising link between olive oil and weight gain. Published in Cell Reports , the research claims that oleic acid, the dominant monounsaturated fat in olive oil, could actually fuel the growth of fat cells — and potentially, your waistline. Led by Michael Rudolph, assistant professor of biochemistry and physiology at the University of Oklahoma College of Medicine, the study dives into how different types of fats affect the body. And the findings are anything but bland. Meet the 'Fat Cell Soldiers' That Olive Oil Might Be Recruiting In a controlled study using mice, Rudolph and his team fed diets high in various fats — from coconut oil to soybean oil — to see how they impacted the body. But only one fat stood out: oleic acid. This compound, abundant in olive oil and processed foods, triggered an increase in the body's 'fat cell soldiers,' or precursor fat cells. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like A neuropatia tem atrapalhado sua rotina? Esse aparelho está ajudando os idosos a ter mais alivio A arte do herbalismo Undo According to Rudolph, oleic acid stimulates a protein called AKT2 while suppressing another called LXR, both of which regulate fat storage. The result? More fat cells ready to store dietary nutrients — and a greater capacity for weight gain. 'If the excess nutrients overtake the number of fat cells, obesity can occur,' Rudolph warned. 'That can then lead to cardiovascular disease or diabetes if not controlled.' iStock Olive oil may be slimming in moderation, but too much could expand your waistline. (Representational image: iStock) Don't Ditch Your Olive Oil Bottle Just Yet Before you throw your olive oil out with the bathwater, there's a crucial caveat. The researchers stress that real-world diets are more complex — no one eats isolated fats in a lab setting. Plus, olive oil still boasts numerous health benefits: it's rich in antioxidants, supports brain function, improves heart health, and has even been linked to reduced cancer and dementia risk. You Might Also Like: No supplements needed: Longevity doctor shares the one daily nutrient that could add years to your life The problem isn't olive oil itself — it's the quantity and context in which it's consumed. Diets dominated by ultra-processed foods rich in oleic acid could tilt the balance. 'Moderation is key,' Rudolph said. 'Relatively balanced levels of oleic acid seem to be beneficial, but higher and prolonged levels may be detrimental.' Olive Oil is Still the Good Guy — Just Not the Only Guy In a world obsessed with 'superfoods,' this study is a wake-up call that even healthy ingredients have their limits. Olive oil remains a nutritional powerhouse — but when consumed in excess or combined with unhealthy food habits, it might be helping your fat cells multiply behind the scenes. So, yes — drizzle that olive oil over your salad. Just don't drown in it. You Might Also Like: Stanford scientists reveal simple dinner hack to stay slim and it starts with what you eat first Olive oil is not always healthy: Here is what you are not being told, nutritionists warn Trying to lose weight? Expert says changing this morning habit can make a big difference
Economic Times
6 hours ago
- Economic Times
'What a magical thing that is': Carl Sagan's wise words on reading books are the fresh breeze we need amid digital brain rot
A resurfaced 1977 Carl Sagan clip warns against intellectual decline, a vital message today as "brain rot" proliferates. Sagan championed reading as a magical connection to past minds and stressed nurturing childhood curiosity. (Images: X/@carlsagandotcom , iStock) A resurfaced video of legendary astronomer Carl Sagan from a 1977 appearance on The Tonight Show is sparking crucial conversations, offering profound insights amidst widespread concerns about dwindling attention spans and the pervasive "brain rot" of the digital era. As screens dominate and algorithms dictate our daily lives, Sagan's wise words on the sheer power of reading books and nurturing curious minds feel less like a relic of the past and more like an urgent plea for our intellectual the captivating 1977 clip, Sagan, a master communicator of science, articulated the almost unbelievable power held within a book. "The whole idea of what happens when you read a book I find absolutely stunning," he told Johnny Carson. He marveled at how "some product of a tree with little black squiggles on it" could open up, revealing "the voice of someone speaking who may have been dead 3,000 years, and yet there he is talking directly to you. What a magical thing that is." This timeless connection through the written word, a direct link to minds across centuries, stands in stark contrast to the fleeting nature of digital content. Sagan didn't stop at the magic of books; he delved into the inherent curiosity of children, a vital "natural resource" he believed we are tragically wasting. He observed that children "start out eager, intellectually wide-eyed, asking extremely clever questions." Yet, he lamented, "something happens, by and large, to discourage them."He highlighted how dismissive responses to profound questions, like "Mommy, why is the grass green?", teach children "there's something bad about using the mind." Sagan warned that in perilous times, facing "complex and subtle problems" requires individuals capable of "complex and subtle solutions"—a capacity nurtured through intellectual engagement and curiosity. Sagan's 1977 observations are eerily prescient today. The Oxford 2024 Word of the Year, "brain rot," encapsulates widespread anxiety about declining attention spans. Data from Gallup and the Bureau of Labor Statistics show a steady decline in American reading habits. In a conversation on NPR, author Elaine Castillo noted that "massive corporations have essentially captured the capacities in us for reading," offering "momentary dopamine hits" that replace reading's restorative aspects. Abdullah Shihipar of Brown University added that reading a book requires a higher "mental load" than casual scrolling, and studies suggest reading physical media is "superior" to screen reading, which often encourages skimming. The education sector sounds a loud alarm. A former English and digital arts teacher, Hannah, recently resigned with a viral video, lamenting that "a lot of kids don't know how to read," and that AI tools are eroding critical thinking. She witnessed students unable to write basic sentences, and essays produced entirely by ChatGPT, with students showing little concern over plagiarism. Hannah's drastic suggestion: "We need to cut it off. Let them learn how to think again."Abdullah Shihipar, in an NPR conversation, cited a Duke study showing a 12% decline in reading comprehension when AI tools were used. Elaine Castillo articulated a deeper fear: that we might "abdicate our own humanity and our capacity to read, to contemplate, to wrestle with difficult concepts." She emphasized reading's role in building empathy and fostering a "capacity for defiance." The statistics are stark: roughly half of American adults read below a sixth-grade level. Beyond cognitive benefits, reading boasts tangible health advantages; Shihipar mentioned a study indicating a 20% decrease in mortality for book readers, independent of wealth or age. Carl Sagan's powerful message from decades ago offers a vital path forward. His emphasis on the magic of books and the nurturing of intellectual curiosity is not just nostalgic; it's a strategic blueprint for preserving our minds, our empathy, and our ability to navigate the complexities of our world. It's time to heed his timeless wisdom.
Time of India
4 days ago
- Time of India
A common drug shows promise for patients with liver disease
A recent Chinese clinical trial published in The BMJ reveals that dapagliflozin, a type 2 diabetes drug, shows promise in treating severe liver conditions like MASH and liver fibrosis. The study, involving 154 participants, demonstrated significant improvements in MASH and fibrosis among those receiving dapagliflozin compared to the placebo group, suggesting a potential new treatment avenue. Liver disease accounts for two million deaths annually. This is 4% of all deaths (1 out of every 25 deaths worldwide), as per the data from 2023. Liver disease is a growing global health concern. A new study suggests that a widely used diabetes medication may offer hope for patients suffering from progressive liver disease. A recent clinical trial conducted in China and published in The BMJ suggests that the type 2 diabetes drug dapagliflozin can help patients with severe liver conditions such as metabolic dysfunction-associated steatohepatitis (MASH) and liver fibrosis, which have limited treatment options. What does the diabetes drug do (Pic courtesy: iStock) Dapagliflozin, a sodium-glucose cotransporter 2 (SGLT-2) inhibitor, which is widely used to treat type 2 diabetes, has been shown to improve progressive liver disease. The Chinese researchers found that the drug improved metabolic dysfunction-associated steatohepatitis (MASH), a condition where excess fat accumulates in the liver, leading to inflammation and liver fibrosis (a buildup of scar tissue). MASH affects more than 5% of adults, and it is also common (30%) in people with diabetes or obesity. Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Switch to UnionBank Rewards Card UnionBank Credit Card Apply Now Undo This can progress to cirrhosis in up to 25% of individuals. Though previous studies have suggested that SGLT-2 inhibitors can improve liver fat content, liver enzymes, and liver stiffness, no trial has been carried out in patients with MASH. The study To understand the effects of dapagliflozin in patients with MASH, the researchers conducted a study. The 48-week study had 154 participants, who were diagnosed with MASH following liver biopsies at six Chinese medical centers from November 2018 to March 2023. Participants had an average age of 35, and 85% were men. Nearly half (45%0 had type 2 diabetes, and most had evidence of liver fibrosis at various stages (33% stage 1, 45% stage 2, 19% stage 3). Following an initial screening biopsy, the participants were randomly assigned to receive 10 mg of dapagliflozin or a matching placebo once daily for 48 weeks. They attended health education sessions twice a year. The researchers also recorded body weight, blood pressure, blood glucose, liver enzymes, physical activity, diet, insulin, and lipids of the participants throughout the trial. MASH improvement was defined as a decrease of at least 2 points in non-alcoholic fatty liver disease activity score (NAS) or a NAS of 3 points or less. By the end of the study, which is after 48 weeks, the researchers observed that 53% (41 of 78) participants in the dapagliflozin group showed improvement in MASH without worsening of fibrosis (defined as no increase in fibrosis stage) compared with 30% (23 of 76) in the placebo group. 23% (18 of 78) participants in the dapagliflozin group showed resolution of MASH without worsening of fibrosis, compared with 8% (6 of 76) in the placebo group. Trump Health Scare: 'Cognitive Decline' Spotted? Political Adviser's BIG Warning Amid Dementia Claim They also saw improvement in fibrosis without worsening of MASH in 45% (35 of 78) participants in the dapagliflozin group compared with 20% (15 of 76) in the placebo group. 1% (1 of 78) in the dapagliflozin group and 3% (2 of 76) in the placebo group discontinued the treatment because of adverse events. What are the experts saying Fatty liver 'Our findings indicate that dapagliflozin may affect key aspects of MASH by improving both steatohepatitis and fibrosis,' they said. They added that large-scale and long-term trials are needed to further confirm these effects. The trial was conducted in a Chinese population, which limits its broader generalisability. They also noted that with the emergence of more drugs, therapeutic decisions will likely become increasingly tailored to individual patient profiles, they write. 'Ideally, such treatments should provide cardiovascular benefit, have an established safety profile, and be accessible to broad and diverse patient populations,' they concluded. One step to a healthier you—join Times Health+ Yoga and feel the change
